Expression of concern for

• Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.

  Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyama S, Iwasaka T. Fujiyama S, et al. Circ Res. 2001 Jan 19;88(1):22-9. doi: 10.1161/01.res.88.1.22. Circ Res. 2001. Retraction in: Circ Res. 2013 Jun 7;112(12):e180. doi: 10.1161/RES.0b013e31829b5cca. PMID: 11139469 Retracted.
• Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase.

  Shibasaki Y, Matsubara H, Nozawa Y, Mori Y, Masaki H, Kosaki A, Tsutsumi Y, Uchiyama Y, Fujiyama S, Nose A, Iba O, Tateishi E, Hasegawa T, Horiuchi M, Nahmias C, Iwasaka T. Shibasaki Y, et al. Hypertension. 2001 Sep;38(3):367-72. doi: 10.1161/01.hyp.38.3.367. Hypertension. 2001. Retraction in: Hypertension. 2013 Jul;62(1):e3. doi: 10.1161/HYP.0b013e31829b66f4. PMID: 11566906 Retracted.
• Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs.

  Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, Kojima H, Iwasaka T. Iba O, et al. Circulation. 2002 Oct 8;106(15):2019-25. doi: 10.1161/01.cir.0000031332.45480.79. Circulation. 2002. Retraction in: Circulation. 2013 Jun 11;127(23):e842. doi: 10.1161/CIR.0b013e31829bd2f4. PMID: 12370229 Retracted.
• Enhancement of ischemia-induced angiogenesis by eNOS overexpression.

  Amano K, Matsubara H, Iba O, Okigaki M, Fujiyama S, Imada T, Kojima H, Nozawa Y, Kawashima S, Yokoyama M, Iwasaka T. Amano K, et al. Hypertension. 2003 Jan;41(1):156-62. doi: 10.1161/01.hyp.0000053552.86367.12. Hypertension. 2003. Retraction in: Hypertension. 2013 Jul;62(1):e3. doi: 10.1161/HYP.0b013e31829b66f4. PMID: 12511546 Retracted.
• Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways.

  Mano A, Tatsumi T, Shiraishi J, Keira N, Nomura T, Takeda M, Nishikawa S, Yamanaka S, Matoba S, Kobara M, Tanaka H, Shirayama T, Takamatsu T, Nozawa Y, Matsubara H. Mano A, et al. Circulation. 2004 Jul 20;110(3):317-23. doi: 10.1161/01.CIR.0000135599.33787.CA. Epub 2004 Jul 12. Circulation. 2004. Retraction in: Circulation. 2013 Jun 11;127(23):e842. doi: 10.1161/CIR.0b013e31829bd2f4. PMID: 15249508 Retracted.